EBUS-TBNA vs Acquire TBNB

Launched by ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST · Dec 13, 2019

Keywords

ClinConnect Summary

The causes of mediastinal lymphadenopathy include infection, reactive lymphadenopathy, granulomatous disorders, and malignancy (metastases from various primaries, lymphoma, thymoma, neurogenic tumours). Radiological appearances are usually inadequate at providing a definitive diagnosis. In granulomatous disorders such as sarcoidosis as well as certain infections including tuberculosis, there is frequently mediastinal or hilar lymph node involvement without evidence of disease activity in other organs or lymph node groups. In malignancy, the metastatic involvement of lymph nodes has importan...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Scheduled for EBUS-TBNA as part of clinical care
• • 2. Lymph node size ≥5mm on CT scan
• • 3. Age \> 18 years
• • 4. Written informed consent
• Exclusion Criteria:
• • 1. Contraindication to needle biopsy (e.g. coagulopathy, anticoagulation, thrombocytopenia, other bleeding diathesis)
• • 2. Inability to obtain informed consent